We evaluated the genotypic origin of mesenchymal stem cells (MSC) following sex-mismatched allogeneic bone marrow transplantation (BMT), and investigated the telomere dynamics in MSC in normal individuals and patients after BMT. The study population consisted of 11 patients with hematologic disorders who showed complete chimerism after BMT. Telomere length was measured in MSC using Southern blotting analysis in eight patients and 18 healthy subjects as a control group. Following culture, MSC were identified by the expression of SH2 and SH4, and lack of CD14, CD34, and CD45. All MSC showed the recipient genotype, based on the results of fluorescent in situ hybridization analysis using X-chromosome satellite probes or microsatellite DNA polymorphism analysis. The mean telomere length in MSC from normal controls was 7.270.53 kb (range, 6.12-7.78), and progressive telomere shortening was seen with age. There was no significant difference in MSC telomere length between the BMT group and age-matched controls. This study confirmed that the MSC isolated from the recipients of allogeneic BMT did not have the donor genotype, despite complete chimerism. Moreover, MSC were demonstrated to show progressive loss of telomere length with age, but the telomeres in MSC were not affected by BMT. Bone Marrow Transplantation (2003) 32, 947-952.
cytotoxic chemotherapy or radiation, for example during the conditioning used for hematopoietic stem cell transplantation (HSCT). [3] [4] [5] [6] [7] [8] This damage might result in impairment of hematopoiesis in BM following HSCT. 9 Recently, studies of stem cell plasticity in the field of HSCT have focused on the origin of MSC after HSCT and the feasibility of stromal cell cotransplantation to enhance engraftment of donor stem cells. 9, 10 Theoretically, BM grafts may also contain MSC and their engraftment would result in chimeric stromal elements. However, in most reports to date, stromal cells were found to be of recipient origin. [11] [12] [13] [14] [15] The telomeres are the terminal portions of eucaryotic chromosomes composed of specific proteins/tandem DNA repeats, and are essential for the stability of chromosomes and genes. 16, 17 Telomeric DNA in humans decreases by 50-100 bp with each somatic cell division, and undergoes progressive shortening with increasing age both in vitro and in vivo. [18] [19] [20] Hematopoietic stem cells after HSCT undergo increased replicative proliferation, resulting in further acceleration of telomere shortening of the progenitor cells. [21] [22] [23] [24] MSC might also undergo excessive proliferative stress during reconstitution after HSCT. Thus, telomere length in MSC is expected to show accelerated shortening following HSCT. However, the stromal microenvironment in BM has been reported to be severely damaged after HSCT, suggesting that decreased cycling may have no effect on telomere length. 6, 8 In this study, we investigated the origin of MSC in patients undergoing allogeneic bone marrow transplantation (BMT). MSC cultured from BM of patients were confirmed to be derived from the host based on microsatellite polymorphism determined by polymerase chain reaction (PCR) analysis or X-chromosome satellite DNA determined by fluorescent in situ hybridization (FISH) analysis, despite complete engraftment with donor-type hematopoietic cells. In addition, we analyzed telomere length in MSC from patients undergoing allogeneic BMT and normal controls by Southern blotting analysis. Telomere length in MSC cultured from normal control subjects showed progressive shortening with age, but there were no significant differences in telomere length in MSC between the BMT group and age-matched putative controls.
Materials and methods

Patients
A total of 11 patients underwent sex-mismatched allogeneic BMT between 1992 and 1998. The patients' characteristics are shown in Table 1 . The patients ranged in age from 6 to 36 years old, and the median period after BMT was 3 years (range, 1-8 years). Engraftment was confirmed by cytogenetic analysis, RBC phenotyping, FISH analysis using an X-chromosome probe, and/or determination of variable number of tandem repeats (VNTR) by PCR amplification. All patients studied were fully engrafted, and were in complete remission at the time of the study.
Normal controls
BM samples were collected from 18 healthy control subjects, ranging in age from 4 to 74 years old, with normal blood counts. The normal control subjects were healthy donors for allogeneic BMT and patients with lymphoma for staging with normal BM morphology.
MSC culture
Mononuclear cells (MNCs) were isolated from all BM samples from patients and normal control subjects by Ficoll-Hypaque density gradient centrifugation. MNC were cultured in Dulbecco's minimal essential medium (GIBCO-BRL, Grand Island, NY, USA) supplemented with 10% fetal bovine serum (GIBCO-BRL) at a density of 1 Â 10 7 cells/30 ml in 175 cm 2 polystyrene flasks. MSC were allowed to adhere for 72 h, followed by media changes every 3-4 days. When culture dishes reached confluence, adherent cells were passaged and replated at a density of 1 Â 10 6 cells/30 ml in 175 cm 2 polystyrene flasks. 5 After three or more passages, the cells were harvested to perform morphologic, phenotypic, or functional studies and telomere length analysis.
Immunophenotypic analysis
To generate mouse monoclonal antibodies, human MSC hydridoma cells expressing SH2 or SH4 (1 Â 10 7 cells) (Osiris Therapeutics, Baltimore, MD, USA) were injected into the abdominal cavities of mice, and the ascites was collected and passed through a protein G-sepharose column. After three passages, the presence of MSC was confirmed by flow cytometry with monoclonal antibodies to SH2, SH4, CD45, CD14, and CD34. CD14-fluorescein isothiocyanate (FITC), CD45-FITC, and CD34-FTIC antibodies were purchased from PharMingen (San Diego, CA, USA). The MSC were incubated for 10 min in 1 ml of 70% ethanol, and then washed with PBS containing 2% BSA. The MSC were incubated with anti-SH2 or SH4 antibody for 30 min at 41C, washed twice, and incubated with FITC-conjugated whole anti-mouse lgG (Sigma, St Louis, MO, USA) for 30 min at 41C. The samples were examined with a FACSCalibur instrument (Becton Dickinson, San Jose, CA, USA), and the data were analyzed using CellQuest software (Becton Dickinson).
Osteogenic differentiation of MSC
To induce osteogenic differentiation, the MSC harvested after three passages were cultured with osteogenic medium (0.1 mm dexamethasone, 10 mm b-glycerol phosphate, 50 mm l-ascorbic acid) for 11 days. The cells were fixed onto ProbeOn Plus microscope slides (Fisher Scientific, Pittsburgh, PA, USA) with 2% formaldehyde, and then developed with Fast Red TR salt (FRT) for 10 min at room temperature to assess alkaline phosphatase activity in osteoblasts. Counterstaining was performed with hematoxylin for 10 min at room temperature.
FISH analysis
To evaluate their chimeric status, the MSC on ProbeOn Plus slides were incubated with Pepsin solution for 5 min at 371C, and washed with PBS. The MSC were pretreated, then subjected to denaturation, hybridization, and amplification using the X-chromosome satellite probe (Vysis Table 1 Characteristics and engraftment kinetics for patients Inc., Downers Grove, IL, USA). At least 200 nuclei were examined in each sample by fluorescence microscopy.
PCR of minisatellite region D1S80
The host or donor origin of MSC cultured from MNC of BM was also determined by PCR amplification of the D1S80 locus, which contains a VNTR. After extraction of genomic DNA from MSC, PCR was performed using a DNA thermal cycler (GeneAmp PCR system 2400; PerkinElmer Cetus, Norwalk, CT, USA) according to the manufacturer's protocol. Briefly, DNA was denatured for 2 min at 951C, followed by 30 cycles of amplification at 941C for 30 s, 651C at 40 s, and 721C for 30 s. After the last cycle, the samples were held at 721C for 10 min, and finally transferred to 41C. Electrophoresis of the amplified DNA was carried out on 2% agarose gels. The amplification products were visualized directly by staining with ethidium bromide.
Measurement of telomere length
Telomere length analyses were carried out as reported previously. 23, 25 Briefly, all MSC obtained from eight patients and 18 normal control subjects after three culture passages were stored at À801C until DNA extraction. Genomic DNA was extracted from the MNC using a genomic DNA extraction kit (Bioneer, Choungwon, Chungbuk, Korea), and the integrity of extracted DNA was confirmed by 0.8% agarose gel electrophoresis. Aliquots of 4 mg of extracted DNA were completely digested with 40 U of RsaI, and the DNA was size fractionated by electrophoresis on 0.7% agarose gels. DNA was transferred onto nylon membranes using the capillary transfer method for Southern blotting. The filters were hybridized with a biotinylated telomere probe (TTAGGG)n (TeloQuant, Pharmingen, San Diego, CA, USA) in hybridization buffer overnight at 651C. The hybridized probe was detected by the chemiluminescence method according to the manufacturer's protocol (TeloQuant). The telomere lengths were assessed quantitatively by densitometric analysis of autoradiographs using a transmitter scanning video densitometer (Bio-rad, Segrate, Milano, Italy). The mean telomere length in each sample was then identified as the peak intensity of the telomere length in kb by densitometry (Figure 1 ).
Statistical analysis
Values are presented as means7s.d. The Mann-Whitney U-test was used for comparison of telomere length between groups. Linear regression analyses were performed to assess the correlation between telomere length and age.
Results
Generation and characteristics of MSC
MSC were successfully cultured from the BM MNC of 11 patients and 18 normal control subjects, and in primary cultures the MSC were seen to be spindle-shaped fibroblastlike cells (Figure 2a) . Following seeding of 2 Â 10 7 MNC in primary cultures, the median MSC harvested was 6.2 Â 10 6 cells (range, 2.0-8.6 Â 10 6 cells) on day 24 (range, days 17-69). The yield of MSC in the patient group was not significantly different from that in the normal control group. The immunophenotype study using flow cytometry indicated that these cells (Figure 2a ) expressed the mesenchymal-related antigens (SH2 and SH4), but not hematopoietic stem cell-related antigens (CD14, CD34, or CD45). Cultured MSC showed a similar phenotype and expression of SH2 and SH4, but not CD14, CD34, or CD45.
Differentiation of MSC to osteoblasts
To determine the differentiation capacities to multiple cell types, the MSC were induced to generate osteoblasts in the presence of osteogenic medium containing dexamethasone, b-glycerol phosphate, and l-ascorbic acid (Figure 2b ). The osteoblasts exhibited strong alkaline phosphatase activity, as demonstrated using FRT (Figure 2c ). In addition, there were no differences in the osteogenic differentiation of MSC harvested after each subculture.
The marrow stroma remained of host origin after BMT Seven patients with aplastic anemia and four patients with leukemia participated in this experiment. Owing to the long interval (1-8 years) after BMT, all patients were off immunosuppressive therapy and had been successfully engrafted, as confirmed by complete donor chimerism demonstrated by FISH analysis for X-chromosome and/or PCR analysis to detect VNTR in separated DNA. However, the MSC derived from BM MNC of the patients showed FISH signals of recipients on analysis of at least 200 MSC using the X-chromosome microsatellite probe (Table 2) , and showed recipient-specific bands on analysis of VNTR (Figures 3 and 4) .
Progressive telomere shortening in MSC of healthy normal controls MSC were harvested from 18 healthy individuals after three culture passages, and telomere length was measured. The mean (7s.d.) telomere length in MSC from normal controls was 7.2070.53 kb (range, 6.12-7.78). This range of differences in telomere length was very narrow as compared with those of MNC in healthy donors reported previously. 23 Nevertheless, a progressive shortening of telomere length was detected in MSC with age (P ¼ 0.001, r ¼ À0.70). The telomere length in MSC of normal healthy control subjects was plotted by the following equation: T ¼ 8.0-0.021 Â A, in which T is the telomere length in kb and A is the age in years ( Figure 5 ).
Telomere length in MSC was not affected by BMT
Telomere length of MSC from eight BMT patients (Table 2) was measured after three culture passages. The mean telomere length (7s.d.) in MSC of the patients following BMT was 7.4170.57 kb (range, 6.23-7.96), and there were no significant differences in telomere length of MSC between the BMT group and age-matched putative controls (7.5970.22 kb) (P ¼ 0.75). 
Discussion
The results of the present study confirm that the stromal cells of the BM microenvironment remain genotypically of host origin after BMT, despite full hematopoietic engraftment with donor-type cells. Although there have been some controversial reports to the contrary, most recent studies have indicated that stromal elements derived from donors do not contribute to reconstitution of the microenvironment after HSCT, even after long-term follow-up of as long as 27 years. [11] [12] [13] [14] [15] [26] [27] [28] [29] The reason for this finding is not clear, but possible explanations for the lack of cells of donor origin include immune-mediated rejection of donor stromal elements, inability to compete effectively with host stromal elements, and the low numbers of stromal cells transplanted. 9 In addition, a recent report suggested that the stromal compartment may be irreversibly damaged by the myeloablative regimens used in the preparation of stem cells for transplantation, and cannot be reconstituted by committed stromal precursors. 13 The feasibility of cotransplantation of MSC during hematopoietic stem cell grafting is very interesting and is a potentially medically important topic. For example, osteogenesis imperfecta patients showed 1.5-2.0% osteoblasts of donor origin following allogeneic HSCT, suggesting a potential therapeutic role of MSC in the field of HSCT. 15 In addition, MSC inhibit T-cell stimulatory capacity, as evidenced by inhibition of primary and secondary mixed lymphocyte reactions. 30 This finding suggests that cotransplantation of MSC may prevent or ameliorate the development of GVHD following allogeneic HSCT. 9 Koc et al 31 reported the results of a clinical trial using MSC in advanced breast cancer patients who underwent autologous transplantation with peripheral blood. MSC infusions given at the time of autologous HSCT contributed to rapid hematopoietic recovery, enhancing neutrophil and platelet engraftment, without any adverse effects as compared with those of historical controls. Currently, there are several clinical trials in progress using allogeneic MSC cotransplantation to improve engraftment and decrease GVHD in patients. 32, 33 Telomere length is maintained by a balance between replication rate and telomerase activity. [18] [19] [20] The telomere length in primitive hematopoietic stem cells decreases despite telomerase activity. This finding explains that telomerase activity in stem cells may be too weak to overcome the shortening of telomere length, especially after HSCT. [21] [22] [23] [24] However, variations have been reported in telomere length among healthy normal controls due to inherited heterogeneity. 34 We found that MSC also showed progressive telomere shortening with age in healthy normal controls. However, as compared with hematopoietic stem cells, the range of differences in telomere length in MSC according to age was very narrow. 23 This finding suggests that stromal cells constituting the microenvironment of BM might require fewer doublings during the lifetime of an individual than hematopoietic stem cells. It has been suggested that critically shortened telomeres in stem cells contribute to age-related clonal disorders, [21] [22] [23] [24] but the significance of the shortened telomeres in MSC remains unclear.
In the present study, there was no significant difference in telomere length in MSC between the BMT group and agematched putative controls. The hematopoietic stem cells after HSCT may be faced with increased replicative proliferation and show accelerated telomere shortening, especially within 1 year after transplantation. [21] [22] [23] [24] However, the telomeres in MSC are not affected by HSCT. While the reason for telomere stabilization is not clear, myeloablative conditioning regimens are known to damage stromal cells, and this may result in deficient proliferation of stromal cells. 6, 8 In conclusion, our findings confirm that the MSC cultured in BM MNC of recipients do not have the donor genotype. Moreover, MSC progressively lose telomere length with age, but the telomeres in MSC are not affected by stem cell transplantation. 310-314. 
